WASP levels in platelets and lymphocytes of Wiskott-Aldrich syndrome patients correlate with cell dysfunction

Journal of Immunology

Volumn 163, Issue 11, 1999, Pages 6314-6320

  Shcherbina, Anna ^a,b   Rosen, Fred S ^a   Remold O'Donnell, Eileen ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Moscow Industrial University   (Russian Federation)

^c CENTER FOR BLOOD RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; RNA; UNCLASSIFIED DRUG; WISKOTT ALDRICH SYNDROME PROTEIN;

ARTICLE; B CELL LYMPHOMA; CELL LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; GENE MUTATION; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; MALE; MONONUCLEAR CELL; NEUTROPHIL; PATIENT CODING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE DYSFUNCTION; WISKOTT ALDRICH SYNDROME;

BLOOD PLATELETS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; CONSANGUINITY; GENE EXPRESSION; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOCYTES; LYMPHOMA, B-CELL; MALE; MUTATION; NEUTROPHILS; PROGNOSIS; PROTEINS; WISKOTT-ALDRICH SYNDROME; WISKOTT-ALDRICH SYNDROME PROTEIN;

EID: 0033485918     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Wiskott, A. 1936. Familiärer, angeborener morbus Werlhofii. Monatschrift Kinderheil 68:212.
2. Aldrich, R. A., A. G. Steinberg, and D. C. Campbell. 1954. Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis, and bloody diarrhea. Pediatrics 13:133.
3. Remold-O'Donnell, E., F. S. Rosen, and D. M. Kenney. 1996. Defects in Wiskott-Aldrich syndrome blood cells. Blood 87:2621.
4. Derry, J. M. J., H. D. Ochs, and U. Francke. 1994. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 78:635.
5. Stewart, D. M., S. Treiber-Held, C. C. Kurman, F. Facchetti, L. D. Notarangelo, and D. L. Nelson. 1996. Studies of the expression of the Wiskott-Aldrich syndrome protein. J. Clin. Invest. 97:2627.
6. Parolini, O., S. Berardelli, E. Riedl, C. Bello-Fernandez, H. Strobl, O. Majdic, and W. Knapp. 1997. Expression of Wiskott-Aldrich syndrome protein (WASP) gene during hematopoietic differentiation. Blood 90:70.
7. Zhu, Q., C. Watanabe, T. Liu, D. Hollenbaugh, R. M. Blaese, S. B. Kanner, A. Aruffo, and H. D. Ochs. 1997. Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood 90: 2680.
8. Kenney, D., L. Cairns, E. Remold-O'Donnell, J. Peterson, F. S. Rosen, and R. Parkman. 1986. Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome. Blood 68:1329.
9. Gallego, M. D., M. Santamaria, J. Peña, and I. J. Molina. 1997. Defective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation. Blood 90:3089.
10. Snapper, S. B., F. S. Rosen, E. Mizoguchi, P. Cohen, W. Khan, C-H. Liu, T. L. Hagemann, S-P. Kwan, R. Ferrini, L. Davidson, A. K. Bhan, and F. W. Alt. 1998. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B Cell activation. Immunity 9:81.
11. Molina, I. J., J. Sancho, C. Terhorst, F. S. Rosen, and E. Remold-O'Donnell. 1993. T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. J. Immunol. 151:4383.
12. Miki, H., K. Miura, T. Takenawa. 1996. N-WASP, a novel actin-depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2-dependent manner downstream of tyrosine kinases. EMBO J. 15:5326.
13. Ramesh, N., I. M. Antón, J. H. Hartwig, and R. S. Geha. 1997. WIP, a protein associated with Wiskott-Aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells. Proc. Natl. Acad. Sci. USA 94:14671.
14. Aspenström, P., U. Lindberg, and A. Hall. 1996. Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott-Aldrich syndrome. Curr. Biol. 6:70.
15. Symons, M., J. M. J. Derry, B. Karlak, S. Jiang, V. Lemahieu, F. McCormick, U. Francke, and A. Abo. 1996. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell 84:723.
16. Kolluri, R., K. F. Tolias, C. L. Carpenter, F. S. Rosen, and T. Kirchhausen. 1996. Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase Cdc42. Proc. Natl. Acad. Sci. USA 93:5615.
17. Brickell, P. M., D. R. Katz, and A. J. Thrasher. 1998. Wiskott-Aldrich syndrome: current research concepts. Br. J. Haematol. 101:603.
18. Snapper, S. B., and F. S. Rosen. 1999. The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization. Annu. Rev. Immunol. 17:907.
19. Remold-O'Donnell, E., J. Cooley, A. Shcherbina, T. L. Hagemann, S.-P. Kwan, D. M. Kenney, and F. S. Rosen. 1997. Variable expression of WASP in B cell lines of Wiskott-Aldrich syndrome patients. J. Immunol. 158:4021.
20. Kwan, S-P, T. L. Hagemann, B. E. Radtke, R. M. Blaese, and F. S. Rosen. 1995. Identification of mutations in the Wiskott-Aldrich syndrome gene and characterization of a polymorphic dinucleotide repeat at DXS6940, adjacent to the disease gene. Proc. Natl. Acad. Sci. USA 92:4706.
21. Kwan, S-P, T. L. Hagemann, R. M. Blaese, A. Knutsen, and F. S. Rosen. 1995. Scanning of the Wiskott-Aldrich syndrome (WAS) gene: identification of 18 novel alterations including a possible mutation hotspot at Arg 86 resulting in thrombocytopenia, a mild WAS phenotype. Hum. Mol. Genet. 4:1995.
22. Thrasher, A. J., G. E. Jones, C. Kinnon, P. M. Brickell and D. R. Katz. 1998. Is Wiskott-Aldrich syndrome a cell trafficking disorder? Immunol. Today 19:537.
23. Haddad, E., E. Cramer, C. Riviëre, P. Rameau, F. Louache, J. Guichard, D. L. Nelson, A. Fischer, W. Vainchenker, and N. Debili. 1999. The thrombocytopenia of Wiskott Aldrich Syndrome is not related to a defect in proplatelet formation. Blood 94:509.
24. Hershfield, M. S., and B. S. Mitchell. 1995. Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. In The Metabolic and Molecular Bones of Inherited Diseases, Vol. 2. C. Scriver, J. B. Stanbury, J. B. Wyngaarden, and D. G. Fredrickson, eds. McGraw-Hill Book Company, New York, NY, p. 1725.
25. 2+-dependent protease in human platelets. J. Biol. Chem. 252:5602.
26. Oda, A., H. D. Ochs, B. J. Druker, K. Ozaki, C. Watanabe, M. Handa, Y. Miyakawa, and Y. Ikeda. 1998. Collagen induces tyrosine phosphorylation of Wiskott-Aldrich syndrome protein in human platelets. Blood 92:1852.
27. 2+-dependent neutral protease) in the destructive thrombocytopenia of the Wiskott-Alridrich syndrome. Br. J. Haematol. 87:773.
28. Derry, J. M. J., J. A. Kerns, K. I. Weinberg, H. D. Ochs, V. Volpini, X. Estivill, A. P. Walker, and U. Francke. 1995. WASP gene mutations in Wiskott-Aldrich syndrome and X-linked thrombocytopenia. Hum. Mol. Genet. 4:1127.
29. Miki, H., S. Nonoyama, Q. Zhu, A. Aruffo, H. D. Ochs, and T. Takenawa. 1997. Tyrosine kinase signaling regulates Wiskott-Aldrich syndrome protein function, which is essential for megakaryocyte differentiation. Cell Growth Differ. 8:195.
30. Ochs, H. D. 1998. The Wiskott-Aldrich syndrome. Springer Semin. Immunopathol. 19:435.
31. Perry III, G. S., B. D. Spector, L. M. Schuman, J. S. Mandel, V. E. Anderson, R. B. McHugh, M. R. Hanson, S. M. Fahlstrom, W. Krivit, and J. H. Kersey. 1980. The Wiskott-Aldrich syndrome in the United States and Canada (1892-1979). J. Pediatr. 97:72.
32. Sullivan, K. E., C. A. Mullen, R. M. Blaese, and J. A. Winkelstein. 1994. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J. Pediatr. 125:876.
33. Cotelingam, J. D., F. G. Witebsky, S. M. Hsu, R. M. Blaese, and E. S. Jaffe. 1985. Malignant lymphoma in patients with the Wiskott-Aldrich syndrome. Cancer Invest. 3:515.
34. MacCarthy-Morrogh, L., H. B. Gaspar, Y.-C. Wang, F. Katz, L. Thompson, M. Layton, A. M. Jones, and C. Kinnon. 1998. Absence of expression of the Wiskott-Aldrich syndrome protein in peripheral blood cells of Wiskott-Aldrich syndrome patients. Clin. Immunol. Immunopathol. 88:22.
35. Yamada, M., M. Ohtsu, I. Kobayashi, N. Kawamura, K. Kobayashi, T. Ariga, Y. Sakiyama, D. L. Nelson, S. Tsuruta, M. Anakura, and N. Ishikawa. 1999. Flow cytometric analysis of Wiskott-Aldrich syndrome (WAS) protein in lymphocytes from WAS patients and their familial carriers. Blood 93:756.
36. Zhu, Q., M. Zhang, R. M. Blaese, J. M. J. Derry, A. Junker, U. Francke, S-H. Chen, and H. D. Ochs. 1995. The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene. Blood 86:3797.
37. Wengler, G. S., L. D. Notarangelo, S. Berardelli, G. Pollonni, P. Mella, A. Fasth, A. G. Ugazio, and O. Parolini. 1995. High prevalence of nonsense, frame shift, and splice-site mutations in 16 patients with full-blown Wiskott-Aldrich syndrome. Blood 86:3648.
38. Schindelhauer, D., M. Weiss, H. Hellebrand, A. Golla, M. Hergersberg, R. Seger, B. H. Belohradsky, and A. Meindl. 1996. Wiskott-Aldrich syndrome: no strict genotype-phenotype correlations but clustering of missense mutations in the amino-terminal part of the WASP gene product. Hum. Genet. 98:68.
39. Schwarz, K. 1996. WASPbase: a database of WAS- and XLT-causing mutations. Immunol. Today 17:496.